NVOcomplete# NVO — The Call
## The Call
I think Novo Nordisk is a great business and a mediocre setup at **$45.71**. I’m not selling the franchise quality — the margins, returns on capital, and balance-sheet leverage are real — but I’m also not pretending this is a layup when **free cash flow is only 28,989,000,000** against **net income of 102,434,000,000**, shareholder payouts ran to **53,151,000,000**, an
NETcomplete# NET — The Call
## The Call
I’m bearish here. Cloudflare is a real business with real demand, but the stock at **$282.91** is priced as if the hard part is already done while the financials still show **-9.27% operating margin**, **-$207.2 million** of operating income, **-$102.3 million** of net income, **-4.22% ROIC**, and a balance sheet carrying **$3.700 billion** of debt. I do not pay **43.1
TCEHYcomplete# TCEHY — The Call
## The Call
I’m constructive here: TCEHY is a high-quality cash machine trading at a reasonable price, and I think the bull case beats the bear case on the actual numbers. At **58.92**, I do not see a bargain-basement setup, but I do see a business with **30.6% net margin**, **190.17B free cash flow**, **0.54x net debt / EBITDA**, and a valuation of just **15.97x earnings** and